Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tadakazu Hisamatsu

Showing results (1-10 of 312) with videos related to

Pageof 32
Sort By:
Immunological Medicine|September 17, 2021
Management of inflammatory bowel disease during the COVID-19 pandemicTadakazu Hisamatsu
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 7, 2014
[Inflammatory bowel disease and colorectal cancer]Tadakazu Hisamatsu
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 11, 2005
[Immunosuppressants for therapy of patients with ulcerative colitis]Tadakazu Hisamatsu, Toshifumi Hibi
Immunological Medicine|August 16, 2021
The impact of maternal exposure to antibiotics on the development of child gut microbiomeJun Miyoshi, Tadakazu Hisamatsu
Clinical Journal of Gastroenterology|December 22, 2024
Effect of maternal exposure to antibiotics during pregnancy on the neonatal intestinal microbiome and healthJun Miyoshi, Tadakazu Hisamatsu
Intestinal Research|July 4, 2017
Treatment and outcomes: medical and surgical treatment for intestinal Behçet's diseaseTadakazu Hisamatsu, Mari Hayashida
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|July 1, 2009
[Biologics in current therapy for inflammatory bowel disease]Tadakazu Hisamatsu, Toshifumi Hibi
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 20, 2018
Immunomodulator and calcineurin inhibitors on inflammatory bowel diseaseMiki Miura, Mari Hayashida, Tadakazu Hisamatsu
Current Opinion in Gastroenterology|July 16, 2008
Innate immunity in inflammatory bowel disease: state of the artTadakazu Hisamatsu, Haruhiko Ogata, Toshifumi Hibi
Clinical Calcium|October 28, 2015
[Inflammatory bowel disease and bone decreased bone mineral density]Tadakazu Hisamatsu, Yasuyo Wada, Takanori Kanai
Pageof 32

Showing results (1-10 of 312) with videos related to

Sort By:
Pageof 32
Immunological Medicine|September 17, 2021
Management of inflammatory bowel disease during the COVID-19 pandemicTadakazu Hisamatsu
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 7, 2014
[Inflammatory bowel disease and colorectal cancer]Tadakazu Hisamatsu
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 11, 2005
[Immunosuppressants for therapy of patients with ulcerative colitis]Tadakazu Hisamatsu, Toshifumi Hibi
Immunological Medicine|August 16, 2021
The impact of maternal exposure to antibiotics on the development of child gut microbiomeJun Miyoshi, Tadakazu Hisamatsu
Clinical Journal of Gastroenterology|December 22, 2024
Effect of maternal exposure to antibiotics during pregnancy on the neonatal intestinal microbiome and healthJun Miyoshi, Tadakazu Hisamatsu
Intestinal Research|July 4, 2017
Treatment and outcomes: medical and surgical treatment for intestinal Behçet's diseaseTadakazu Hisamatsu, Mari Hayashida
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|July 1, 2009
[Biologics in current therapy for inflammatory bowel disease]Tadakazu Hisamatsu, Toshifumi Hibi
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 20, 2018
Immunomodulator and calcineurin inhibitors on inflammatory bowel diseaseMiki Miura, Mari Hayashida, Tadakazu Hisamatsu
Current Opinion in Gastroenterology|July 16, 2008
Innate immunity in inflammatory bowel disease: state of the artTadakazu Hisamatsu, Haruhiko Ogata, Toshifumi Hibi
Clinical Calcium|October 28, 2015
[Inflammatory bowel disease and bone decreased bone mineral density]Tadakazu Hisamatsu, Yasuyo Wada, Takanori Kanai
Pageof 32